Cellular Biomedicine Group

$18.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-0.82%) As of 2:57 PM UTC today

Why Robinhood?

You can buy or sell CBMG and other stocks, options, and ETFs commission-free!

About CBMG

Cellular Biomedicine Group, Inc. Common Stock, also called Cellular Biomedicine Group, is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY. The listed name for CBMG is Cellular Biomedicine Group, Inc. Common Stock.

CEO

Bi Zuo Liu

Employees

217

Headquarters

Gaithersburg, Maryland

Founded

2009

Market Cap

354.79M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

28.03K

High Today

$18.16

Low Today

$18.09

Open Price

$18.13

Volume

1.19K

52 Week High

$19.50

52 Week Low

$11.48

Collections

CBMG Earnings

-$0.88

-$0.59

-$0.29

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours